help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SANO, A.
Right arrow Articles by LEFF, A. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SANO, A.
Right arrow Articles by LEFF, A. R.

Am. J. Respir. Crit. Care Med., Volume 159, Number 6, June 1999, 1903-1909

Inhibition of cPLA2 Translocation and Leukotriene C4 Secretion by Fluticasone Propionate in Exogenously Activated Human Eosinophils

AKIKO SANO, NILDA M. MUÑOZ, HIROYUKI SANO, JOHN CHOI, XIANGDONG ZHU, BENJAMIN JACOBS, and ALAN R. LEFF

Section of Pulmonary and Critical Care Medicine, Department of Medicine, and Departments of Pharmacological and Physiological Sciences and Committees on Clinical Pharmacology and Cellular Physiology, The University of Chicago, Chicago, Illinois

We examined the effect of the highly lipophilic corticosteroid, fluticasone propionate (FP), in causing (1) inhibition of nuclear translocation of cytosolic phospholipase A2 (cPLA2), and (2) blockade of leukotriene C4 (LTC4) synthesis in isolated human eosinophils in vitro. Eosinophils were isolated from peripheral blood, treated with either buffer or 10-10 M to 10-6 M FP in the presence of 10 pg/ml human recombinant interleukin-5 (rhIL-5) and activated with formyl-met-leu-phe (FMLP) + cytochalasin B (CB). At 24 h, stimulated LTC4 secretion from eosinophils was unchanged; however, when corrected for cell viability, LTC4 secretion decreased from 1,429 ± 327 pg/106 cells to 762 ± 113 pg/106 cells for eosinophils treated for 48 h with >=  10-8 M FP (p < 0.003). FMLP/CB-stimulated translocation of cPLA2 to the nuclear envelope assessed by specific immunohistochemical staining also was blocked by FP. By contrast, membrane expression of annexin-1, which was not minimal at 30 min, was substantial at 48 h for eosinophils treated with > 10-10 M FP, and inhibition of LTC4 synthesis was reversed by exogenous arachidonic acid (AA). We find that FP causes a decrease in stimulated eosinophil secretion of LTC4 that is regulated by phospholipase A2 (PLA2). Inhibition of LTC4 synthesis precedes the global cytotoxic effects of FP as indicated by the simultaneous upregulation of annexin-1 expression. Inhibited stimulated secretion corresponds to inhibited translocation of cPLA2 to the nuclear envelope during cellular activation.




This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
A. Y. Meliton, N. M. Munoz, X. Zhu, and A. R. Leff
Attenuated translocation of group IVa phospholipase A2 and up-regulated annexin-1 synthesis by glucocorticoid blocks {beta}2-integrin adhesion in neutrophils
J. Leukoc. Biol., February 1, 2008; 83(2): 344 - 351.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
A. R. Leff and N. M. Munoz
Future Treatment to Lessen Exacerbations of Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, December 1, 2007; 4(8): 659 - 666.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
N. Flamand, J. Lefebvre, G. Lapointe, S. Picard, L. Lemieux, S. G. Bourgoin, and P. Borgeat
Inhibition of platelet-activating factor biosynthesis by adenosine and histamine in human neutrophils: involvement of cPLA2{alpha} and reversal by lyso-PAF
J. Leukoc. Biol., May 1, 2006; 79(5): 1043 - 1051.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
A.R. Leff
From the Authors
Eur. Respir. J., August 1, 2004; 24(2): 334 - 334.
[Full Text] [PDF]


Home page
Eur Respir JHome page
A. Papi
Investigating the steroids and long-acting {beta}2-agonists combination: why do we need more?
Eur. Respir. J., April 1, 2004; 23(4): 501 - 502.
[Full Text] [PDF]


Home page
Eur Respir JHome page
S. Myo, X. Zhu, S. Myou, A.Y. Meliton, J. Liu, E. Boetticher, A.T. Lambertino, C. Xu, N.M. Munoz, and A.R. Leff
Additive blockade of {beta}2-integrin adhesion of eosinophils by salmeterol and fluticasone propionate
Eur. Respir. J., April 1, 2004; 23(4): 511 - 517.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. M. Munoz, Y. J. Kim, A. Y. Meliton, K. P. Kim, S.-K. Han, E. Boetticher, E. O'Leary, S. Myou, X. Zhu, J. V. Bonventre, et al.
Human Group V Phospholipase A2 Induces Group IVA Phospholipase A2-independent Cysteinyl Leukotriene Synthesis in Human Eosinophils
J. Biol. Chem., October 3, 2003; 278(40): 38813 - 38820.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
T. Terashima, K. Amakawa, A. Matsumaru, and K. Yamaguchi
Correlation Between Cysteinyl Leukotriene Release From Leukocytes and Clinical Response to a Leukotriene Inhibitor
Chest, November 1, 2002; 122(5): 1566 - 1570.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
N. M. Munoz, G. A. van Seventer, R. T. Semnani, and A. R. Leff
Augmentation of LTC4 synthesis in human eosinophils caused by CD3-stimulated Th2-like cells in vitro
Am J Physiol Lung Cell Mol Physiol, June 1, 2000; 278(6): L1172 - L1179.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. S. Douglas, A. R. Leff, and A. I. Sperling
CD4+ T Cell and Eosinophil Adhesion Is Mediated by Specific ICAM-3 Ligation and Results in Eosinophil Activation
J. Immunol., March 15, 2000; 164(6): 3385 - 3391.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
P. P Hood, T. P Cotter, J. F Costello, and A. P Sampson
Effect of intravenous corticosteroid on ex vivo leukotriene generation by blood leucocytes of normal and asthmatic patients
Thorax, December 1, 1999; 54(12): 1075 - 1082.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1999 American Thoracic Society